Axe Compute Inc AGPU

Q2 FY2026 · ended Jun 30, 2026 · Revenue $3.21M, +119772.9% YoY · Filed Aug 14, 2026

Axe Compute Inc (AGPU) files with the SEC under industry code 6199, Finance Services. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $3.2 million and a net loss of $17.2 million. Free cash flow was $4.0 million. As of Jun 30, 2026 it held $21.9 million in cash and investments and $1.2 million in total debt.

Revenue
$3.21M
+119772.9% vs year-ago quarter
Net income
$-17.21M
-731.0% vs year-ago quarter
Operating cash flow
$21.12M
+740.9% vs year-ago quarter
Free cash flow
$4.02M
+221.9% vs year-ago quarter
EPS
—
Dividend per share
None
Shares outstanding
11.59M
+6.4% vs year-ago quarter
Net cash
$20.66M
Q2 FY2026
Operating margin
-6161.5%
TTM

Company profile

Industry
Finance Services (SIC 6199)
Listed as
AGPU (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Miami, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1446159
Former names
Axe Compute Inc. (until Oct 5, 2026); Predictive Oncology Inc. (until Dec 11, 2025); Precision Therapeutics Inc. (until Jun 4, 2019); Skyline Medical Inc. (until Feb 6, 2018); BioDrain Medical, Inc. (until Aug 7, 2013)

Other Finance Services companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Revenue
$3.2M
$35,311
$8,674
$3,618
$2,682
Operating income
-$17.3M
-$7.7M
-$172.7M
-$3.3M
-$2.7M
Net income
-$17.2M
-$7.7M
-$150.9M
-$77.7M
-$2.1M
Operating cash flow
$21.1M
-$3.7M
-$3.9M
-$1.7M
-$3.3M
Free cash flow
$4.0M
-$3.8M
-$3.9M
-$1.7M
-$3.3M
Total assets
$100.4M
$45.2M
$52.9M
$3.1M
$3.4M
Total liabilities
$66.3M
$5.0M
$5.2M
$80.6M
$5.1M
Stockholders' equity
$34.0M
$40.3M
$47.7M
-$77.4M
-$1.7M
Cash and investments
$21.9M
$6.9M
$10.8M
$181,667
$506,078
Total debt
$1.2M
$1.4M
$1.6M
$1.7M
$1.8M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Officer or director change
Nov 2, 2026 Oct 27, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Oct 5, 2026 Sep 30, 2026
8-K Current report
Material agreement, Acquisition or sale of assets
Sep 17, 2026 Sep 11, 2026
8-K Current report
Other events
Aug 17, 2026 Aug 17, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 14, 2026 Aug 14, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.